FeesSafety
Pluang+

Virtus Investment Partners remains a 'Hold' amid outflows and weak equity performance despite low valuation.

Market News
09 Nov 2026, 20:10 WIB
Seeking Alpha
View Source
Bearish
Virtus Investment Partners remains a 'Hold' amid outflows and weak equity performance despite low valuation.

Virtus Investment Partners faces ongoing challenges with significant net outflows at a 17% annualized rate and only 5% of its equity assets outperforming benchmarks. Operating margins have shrunk to 28.7% due to declining revenues, although the company maintains a strong balance sheet and a secure 7.4% dividend yield. Despite a low price-to-earnings ratio of 6.3 times for 2026 estimates, continued asset under management and earnings declines limit potential upside. The current valuation fairly reflects these fundamental challenges, leading analysts to maintain a 'Hold' rating on the stock.

Virtus Investment Partners is the subject, with Pluang's Financials-sector data as context for readers. As of Nov 10, 2026 00:52 WIB, out of 142 priced Financials-sector US stocks tradable on Pluang, 129 rose and 12 fell. Notable movers include WULF (TeraWulf Inc) at USD 12.20 with a 7.30% increase, BEN (Franklin Resources, Inc.) at USD 36.01 up 6.74%, and HUT (Hut 8 Corp) at USD 56.08 rising 6.51%.

More News

Quadient reports 34.47M shares and 34.09M net voting rights as of October 30, 2026

Quadient reports 34.47M shares and 34.09M net voting rights as of October 30, 2026

Quadient S.A. disclosed its monthly update on shares and voting rights as of October 30, 2026. The company has a total of 34,468,912 ordinary shares and a net total of 34,091,172 voting rights. This information is relevant for shareholders and invest...

Company Fundamentals
Neutral
1 hour ago
Quadient reports total shares and voting rights as of October 30, 2026.

Quadient reports total shares and voting rights as of October 30, 2026.

Quadient S.A. has disclosed its monthly update on the total number of ordinary shares and voting rights as of October 30, 2026. The company reports 34,468,912 total shares and theoretical voting rights, with 34,091,172 net voting rights. This disclos...

Company Fundamentals
Neutral
1 hour ago
ADC Therapeutics beats Q3 2026 earnings estimates with rising ZYNLONTA sales and strong cash position.

ADC Therapeutics beats Q3 2026 earnings estimates with rising ZYNLONTA sales and strong cash position.

ADC Therapeutics reported a smaller adjusted loss per share of $0.16 in Q3 2026, beating the expected $0.21 loss, and revenue of $21.72 million, surpassing estimates of $18.7 million. The company’s main product, ZYNLONTA, continues to drive growth, w...

Company Fundamentals
Bullish
2 hours ago
Nokia transfers 847,057 treasury shares to employees under incentive programs.

Nokia transfers 847,057 treasury shares to employees under incentive programs.

Nokia has transferred 847,057 of its treasury shares to employees participating in its stock-based incentive programs, as per a board decision announced in October 2025. This transfer was done without compensation, fulfilling commitments under the in...

Company Fundamentals
Neutral
2 hours ago
Nokia transfers 847,057 shares to incentive plan participants, reducing its own holdings.

Nokia transfers 847,057 shares to incentive plan participants, reducing its own holdings.

Nokia Corporation transferred 847,057 of its own shares to participants of its equity-based incentive plans without any payment, following a board resolution. This transfer fulfills Nokia's commitments under these plans and reduces the company's own ...

Company Fundamentals
Neutral
2 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App